Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
D&D Pharmatech is a biopharmaceutical company focused on developing innovative new drugs for the treatment of neurodegenerative diseases (such as Alzheimer's and Parkinson's) and metabolic diseases (such as non-alcoholic steatohepatitis and obesity). The company's primary business areas involve the research and development of new drug candidates utilizing oral GLP-1 receptor agonists and neuroinflammation modulators. D&D Pharmatech operates within the pharmaceutical and biotechnology industries.
디앤디파마텍은 신경퇴행성 질환(알츠하이머병, 파킨슨병 등) 및 대사성 질환(비알코올성 지방간염, 비만 등) 치료를 위한 혁신 신약 개발에 주력하는 바이오 제약 기업입니다. 주요 사업 영역은 경구용 GLP-1 수용체 작용제와 신경염증 조절 물질을 활용한 신약 후보 물질의 연구 개발입니다. 이 회사는 제약 및 바이오 산업에 속해 있습니다.
